Oxford Biomedica Solutions
Malcolm Eaton currently serves as the Senior Manager of Quality Systems at Oxford Biomedica, a role assumed in May 2023, where responsibilities include leading the Quality Systems, Document Control, and Training teams, as well as transitioning the company to a computer-based Quality system. Prior to this, Malcolm held various positions at Resilience, including Interim Head of Technical Quality, where oversight of the Technical Quality Department was provided. During a career in the US Navy, Malcolm operated as a Program Manager for submarine exercises and as a Submarine Officer focusing on operational safety. Academic credentials include a Master of Science in Engineering Management from Duke University and a Bachelor's degree in Physics and Computer Science from Wheaton College.
This person is not in any offices
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.